Immune Therapeutics Inc (OTCQB:IMUN)

0.0295
Delayed Data
As of 3:54pm ET
 -0.0015 / -4.84%
Today’s Change
0.01
Today|||52-Week Range
0.09
+41.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.0016.2K3.5K0.00
 
 
 
Depreciation And Amortization2.9M594.8K1.6K826.00
 
 
 
 
 
 
Operating ExpensesGross Income-2.9M-----826.00
 
 
 
General Expenses30.7M10.0M9.5M5.3M
 
 
 
 
 
Other Operating Expenses0.0046.2K0.000.00
 
 
Research And Development7.5M977.2K444.2K399.4K
 
 
 
 
 
Total Operating Expenses33.6M10.6M9.5M5.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.6M-10.6M-9.5M-5.3M
 
 
 
 
 
Extraordinary Credit0.00--0.00866.5K
 
 
Extraordinary Charge-15.9M-6.1M-6.8M-2.3M
 
 
 
 
 
Interest Expense On Debt388.2K271.0K3.4M1.2M
 
 
 
 
 
Other Expenses-780.000.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-49.9M-16.9M-19.8M-7.9M
 
 
 
 
 
Minority Interest-1.7M-635.7K-297.6K-618.2K
 
 
 
 
 
Net Income-48.3M-16.3M-19.5M-7.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS98.5M153.2M216.7M320.7M
 
 
 
 
 
Shares To Calculate EPS Diluted98.5M153.2M216.7M320.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.49-$0.11-$0.09-$0.02
 
 
 
 
 
EPS Diluted-$0.49-$0.11-$0.09-$0.02